Cancer
Malignant Lip and Oral Cavity Neoplasm
CI-CAN-00001138Explore in graph →
Top-level149 active trials2 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001138Explore in graph →
Clinical trials
554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (53)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05030597 | Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma(FAPI-OSCC) | unknown | — | 100 | Zhongnan HospitalOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06425146 | Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)(TACO) | unknown | N/A | 30 | Centre Leon BerardOTHER | 1 | Aug 22, 2024 |
| clinicaltrials |
| NCT05719779 | Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.(Ronco-Onco) | unknown | N/A | 35 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT03784066 | Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity(DUTRELASCO) | unknown | Phase 1 / Phase 2 | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04277858 | Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.(NECTORS) | unknown | Phase 2 | 60 | Nader SadeghiOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT06060288 | Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening | unknown | — | 174 | Cairo UniversityOTHER | 0 | Oct 3, 2023 | clinicaltrials |
| NCT06016400 | Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma | unknown | Phase 2 / Phase 3 | 412 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05610293 | T1 Squamous Cell Carcinomas of the Lip | unknown | — | 300 | Maastricht University Medical CenterOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05992610 | Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy(iCHRTL) | unknown | N/A | 40 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05902455 | Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis | unknown | — | 40 | Tampere University HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05927220 | WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA | unknown | — | 81 | Armed Forces Institute of Pathology RawalpindiOTHER_GOV | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05876247 | Articulatory Adaptation Following Oral Cancer Treatment(SPOKE) | unknown | — | 50 | University Medical Center GroningenOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05843032 | 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment | unknown | N/A | 27 | Rigshospitalet, DenmarkOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05803915 | Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy | unknown | Phase 2 | 57 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05766150 | Oral Microbioma and Oral Malignant Disease | unknown | — | 300 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT05740774 | Surgical Margin Assessment by 3D Ultrasound | unknown | N/A | 7 | Rigshospitalet, DenmarkOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05578170 | Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma(PROBES) | unknown | — | 47 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT05611463 | Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients(CHANCE) | unknown | Phase 2 | 25 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05604105 | Oral Cancer Awareness in Egypt | unknown | — | 5,000 | Ayat Gamal-AbdelNaserOTHER | 0 | Nov 3, 2022 | clinicaltrials |
| NCT05003427 | 68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05024383 | Dissecting the Heterogeneity of Oral Cancer Pain | unknown | N/A | 80 | NYU College of DentistryOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | unknown | Phase 2 | 1,000,000 | Cairo UniversityOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT04955197 | Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions | unknown | — | 48 | Cairo UniversityOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT02748707 | Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study(ERLO-XIB) | unknown | Phase 2 | 64 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05296811 | Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects. | unknown | N/A | 15 | hassan harby mohamedOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT05150509 | Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy(OSCC) | unknown | — | 110 | DR. MALA KHANOTHER_GOV | 1 | Feb 22, 2022 | clinicaltrials |
| NCT04367909 | A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma | unknown | Phase 2 | 68 | Xin-Hua XuOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03843515 | Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction(NeoNivo) | unknown | Phase 1 | 17 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT04919460 | Research on Optimization and Evaluation of Oral Cancer Screening Methods | unknown | Early Phase 1 | 10,000 | Hunan Cancer HospitalOTHER | 0 | Jun 9, 2021 | clinicaltrials |
| NCT04270201 | Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population(ALDH2020) | unknown | — | 300 | Instituto do Cancer do Estado de São PauloOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT03923881 | MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases(OPUS) | unknown | N/A | 20 | University Medical Center GroningenOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04732741 | Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions | unknown | — | 69 | Cairo UniversityOTHER | 0 | Feb 1, 2021 | clinicaltrials |
| NCT04670146 | Understanding Non-radiotherapy-based Development of Trismus | unknown | N/A | 128 | KU LeuvenOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04543266 | Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning | unknown | — | 500 | The University of Hong KongOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT04487938 | Oral Cancer Screening and Education in Hong Kong | unknown | — | 3,190 | The University of Hong KongOTHER | 0 | Jul 27, 2020 | clinicaltrials |
| NCT03877159 | Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma | unknown | — | 100 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04163029 | Oral Care Study of Postoperative Infections | unknown | — | 50 | University of LiegeOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04387682 | Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients | unknown | N/A | 130 | National Taiwan University HospitalOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT03440151 | Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma | unknown | N/A | 64 | Cairo UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT03418454 | The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw | unknown | — | 150 | Barzilai Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT04214912 | Personalized Survivor Care Plan for Oral Cancer Patients-Effects on Physical-Psychological Functions and Return-to-Work | unknown | N/A | 300 | National Taiwan University HospitalOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT04065737 | Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization(STOP) | unknown | Phase 2 | 29 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT03686020 | Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)(CYFRA21-1) | unknown | — | 24 | Cairo UniversityOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02663583 | Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell | unknown | — | 44 | M.D. Anderson Cancer CenterOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT03917524 | Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.(CTC) | unknown | — | 180 | Chang Gung Memorial HospitalOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03121313 | Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+ | unknown | Phase 2 | 68 | Chang Gung Memorial HospitalOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT03619304 | Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line | unknown | N/A | 20 | Cairo UniversityOTHER | 0 | Jan 30, 2019 | clinicaltrials |
Data updated 22 days agoSource updated May 28, 2025source: clinicaltrials